Coverage of "Anktiva" on Cryptosearcher: the stories and the context behind them.
ImmunityBio shares rose sharply after the UAE approved its cancer drug ANKTIVA for bladder and lung cancer, broadening the therapy’s international scope with strong trial results backing the decision.
July 30, 2026
